Background {#Sec1}
==========

The shikimic acid (SA) pathway exists in prokaryotes and plants, and is the common route for the synthesis of aromatic amino acids (Trp, Phe, Tyr) \[[@CR1]--[@CR3]\] and vitamins such as phylloquinone \[[@CR4]\]. Since its discovery, the SA pathway has attracted extensive interest from science and industries. Recent investigations have demonstrated that more chemicals can be produced by expanding the SA pathway \[[@CR5]\]. Seven steps of reactions complete the SA pathway, leading to the conversion of phosphoenolpyruvate (PEP) and erythrose 4-phophate (E4P) to chorismic acid \[[@CR1]\]. In *Corynebacterium glutamicum,* the *aro* genes encoding DAHP synthase (*aroG/ncgl2098*), 3-dehydroquinate synthase (*aroB/ncgl1559*), 3-dehydroquinate dehydratase (*aroD/ncgl0408*) and shikimate dehydrogenase (*aroE/ncgl1567*) are involved in conversion of PEP and E4P to shikimic acid, and they are located at different transcriptional regulation units \[[@CR6]--[@CR9]\] (Fig. [1](#Fig1){ref-type="fig"}). Recent study showed that transcription of *aroE* was correspondent to the levels of shikimate in *C. glutamicum* \[[@CR9]\]. Genes encoding the enzymes of SA pathway are not continuous on genome and are differently regulated; this would results in extra difficulties for genetic manipulation and metabolic engineering of SA pathway.Fig. 1Overview of shikimic acid pathway (**a**) and location of its encoding genes in *C. glutamicum* chromosome (**b**). *aroG* codes for 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase, *aroB* for 3-dehydroquinate synthase, *aroD* for 3-dehydroquinate dehydratase and *aroE* for shikimate dehydrogenase

The development of synthetic biology brings new concepts to design and construct genetic modules or metabolic engineering for bioprocesses. Genetic elements that regulate transcription, translation or encode various enzymes are used as "parts" to build genetic modules \[[@CR10], [@CR11]\]. Ideally, the properties of the parts and modules can be accurately and quantitatively predicted when they are implanted into chassis cells \[[@CR12], [@CR13]\]. Recently, scientists have designed and constructed a series of parts libraries of promoters, ribosome binding sites (RBS) and terminators, which enabled the regulation of gene expression over wide dynamic ranges in *Escherichia coli* cells \[[@CR14], [@CR15]\]. For example, RBS of different strengths have been applied to optimize the metabolic flux of mevalonate-based farnesyl pyrophosphate biosynthetic pathway \[[@CR16]\]. So far, synthetic parts and modules are very limited for *C. glutamicum*, an important industry production workhorse that has been used for decades to produce amino acids, vitamins, nucleotides \[[@CR17]--[@CR20]\], and recently biofuels and chemicals \[[@CR21]--[@CR24]\].

In this study, efforts were made to construct continuous genetic modules for SA pathway with synthetic biology logistics. Four RBS libraries that were tailored for *C. glutamicum* and 9 genetic modules for SA synthesis were constructed. The functionality and efficiency of the constructed SA pathway modules were evaluated by determination of SA production with *C. glutamicum*. Results suggested that the newly constructed pathway modules were effective. During batch and fed-batch fermentation, SA production reached titers of 7.4 and 11.3 g/L, respectively. This represented the highest titer of fermentative production of SA with *C. glutamicum*.

Results {#Sec2}
=======

Design, construction, and screening of RBS libraries for *aroB*, *aroD*, *aroE* and *aroG* {#Sec3}
------------------------------------------------------------------------------------------

RBS sequences such as AGAAAGGAGG and GAAAGGAGG \[[@CR25]--[@CR27]\] had been previously identified in *C. glutamicum*. In addition, the sequence of AAAGGAGGA had been used for expression of genes involving in biopolyester synthesis with *C. glutamicum* \[[@CR28]\]. All these RBS sequences shared a common feature of AAAGGAGG, which is correspondent to the anti-Shine-Dalgarno sequence at the 3'-end of the 16S rRNA from corneybacteria \[[@CR26]\]. In addition, it was reported that the spaces between RBS and translational start codon were found to be dominantly 5--10 nucleotides in *C. glutamicum* \[[@CR27]\]. Based on these observations, we generalized a seeding sequence of AAAGG(N)~6--9~. According to this design, a pool of RBS sequences was chemically synthesized.

For easy screening of RBS sequences of different strengths and for the purpose to prevent the influence of neighboring elements on gene translation, the enhanced green fluorescence protein (eGFP) \[[@CR29]\] and the ribozyme-based insulator RiboJ \[[@CR30]\] genes were applied to make constructions for screening tailored RBS libraries for individual *aroG*, *aroB*, *aroD* and *aroE*. Construction and screening of the tailored RBS libraries are diagramed in Fig. [2](#Fig2){ref-type="fig"}. As showed in Fig. [2](#Fig2){ref-type="fig"}, 146, 52, 59 and 54 clones were randomly selected for *aroB*, *aroD*, *aroE* and *aroG*, respectively. Plasmids harboring RBS sequences of different strengths were extracted from *E. coli* clones, and were further sequenced. These plasmids were then transferred into *C. glutamicum*. RBS of different strengths were screened by quantification of fluorescence intensities in *C. glutamicum*, and finally 4 RBS libraries were obtained that had 33, 43, 49 and 42 members for *aroB*, *aroD*, *aroE* and *aroG*, respectively. The RBS sequences of these libraries and the strength of individual RBS are showed in Fig. [3](#Fig3){ref-type="fig"}. As seen from Fig. [3](#Fig3){ref-type="fig"}, the strengths of the RBS libraries spanned wide ranges. Specifically, the individual RBS strengths of *aroB*, *aroD*, *aroE* and *aroG* libraries had 70, 21, 19 and 10-folds differences, respectively.Fig. 2Procedures of construction and screening of RBS libraries tailored for *aroG*, *aroB*, *aroD* and *aroE.* Numbers of RBS sequences in each library are represented by the clone numbers of *E. coli* or *C. glutamicum*Fig. 3Quantification of RBS strength in *C. glutamicum* by measuring fluorescence emitted from eGFP fusion proteins with AroG (**a**), AroB (**b**), AroD (**c**), or AroE (**d**). Columns appeared in dark were RBS selected for construction of genetic modules

Construction and evaluation of genetic modules for SA pathway {#Sec4}
-------------------------------------------------------------

The above RBS libraries were exploited to build up genetic modules for SA pathway. Each genetic module had *aroB*, *aroD*, *aroE* and *aroG* genes that were independently regulated by RBS of different strengths. The organization of the genetic modules is generalized in Fig. [4a](#Fig4){ref-type="fig"}. To simplify the construction and evaluation of genetic modules, RBS with relative high (H), medium (M) or low (L) strength (Fig. [3](#Fig3){ref-type="fig"}) from each of the four libraries, were selected for *aroG*, *aroB*, *aroD* or *aroE*. Starting with these building blocks (3 RBS of different strengths and 4 genes with the order of *aroG*-*aroB*-*aroD*-*aroE*), there were theoretical 81 combinations (*i.e.* genetic modules that possible have different levels of gene expression). By using a mathematic model of combinatorial approach, such 81 combinations were scaled down to 9 combinations (Fig. [4](#Fig4){ref-type="fig"}c).Fig. 4The components and structure of the genetic modules (**a**) and AroE activities from cellular lysates of *C. glutamicum* harboring various genetic modules (**b**). In panel **b**, the RBS were determined by a combinatorial approach (**c**). For each *aroG*, *aroB*, *aroD* and *aroE* gene, three levels of RBS strength \[high (H), medium (M), low (L), see Fig. [3](#Fig3){ref-type="fig"}\] were selected, and totally 9 genetic modules were obtained. Three parallel experiments for AroE activity were performed and the standard deviations are showed in panel **b**

Genetic modules of the above 9 combinations were constructed and were inserted into pXMJ19. Thus, 9 pXMJ19 derivatives, namely plasmid-1 to plasmid-9, were obtained and were transferred into *C. glutamicum* RES167*ΔaroK* cells. To determine that if gene translations in the genetic modules were exactly correlated to their RBS strengths as they were previously determined, shikimate dehydrogenase (AroE) activities were determined. As shown in (Fig. [4](#Fig4){ref-type="fig"}b), those modules (G^H^B^L^D^L^E^L^, G^M^B^H^D^M^E^L^, and G^L^B^M^D^H^E^L^) harbored low strengths of RBS exhibited low AroE activities and those modules (G^H^B^H^D^H^E^H^, G^M^B^M^D^L^E^H^, and G^L^B^L^D^M^E^H^) harbored higher strengths of RBS exhibited higher AroE activities. These results suggested that levels of gene translations in the 9 genetic modules were highly correlated to RBS strengths determined previously *via* EGFP fluorescence intensities.

Genetic modules increased SA synthesis with *C. glutamicum* {#Sec5}
-----------------------------------------------------------

In order to obtain a mutant that accumulated SA, the *aroK* that encodes shikimate kinase was deleted from *C. glutamicum* RES167, generating the mutant RES167*ΔaroK*. Plasmids (Table [1](#Tab1){ref-type="table"}) harboring the SA pathway modules (Fig. [4](#Fig4){ref-type="fig"}c) were transferred into *C. glutamicum* RES167*ΔaroK* cells and the effect of those genetic modules on SA production was observed. Results showed that the SA production varied significantly among different genetic modules (Fig. [5](#Fig5){ref-type="fig"}), although the growth of *C. glutamicum* was not affected by those genetic modules (Data not shown). The SA production with RES167*ΔaroK*/plasmid-2 that carried genetic module of G^H^B^M^D^M^E^M^ was 6.8 higher than that of RES167*ΔaroK*, suggesting that the module of G^H^B^M^D^M^E^M^ was the most effective combination for SA synthesis in *C. glutamicum*.Table 1Bacterial strains and plasmids used in this studyStrains/plasmidsRelevant characteristicsSource/reference/notesStrains*E. coli* DH5αF^−^ *endA1thi-1 recA1 relA1 gyrA96deoRΦ*80*dlac*Δ(*lac*Z) M15 Δ(*lacZYA-argF*)*U169hsdR17*(r~K~ ^−^, m~K~ ^+^) λ^−^ *supE44 phoA*Invitrogen*C. glutamicum* RES167Restriction-deficient mutant of ATCC 13032, Δ(*cglIM-cglIR-cglIIR*)University of BielefeldRes167*∆aroK*Res167 derivate, a fragment of DNA encoding for *aroK* was deletedThis studyRes167*∆aroK*/pZB-*aroG*Res167*∆aroK* derivate, containing plasmid pZB-*aroG*This studyRes167*∆aroK*/pZB-*aroB*Res167*∆aroK* derivate, containing plasmid pZB-*aroB*This studyRes167*∆aroK*/pZB-*aroD*Res167*∆aroK* derivate, containing plasmid pZB-*aroD*This studyRes167*∆aroK*/pZB-*aroE*Res167*∆aroK* derivate, containing plasmid pZB-*aroE*This studyPlasmidspK18*mobsacB*Mobilizable vector, for gene disruption in *C. glutamicum*University of BielefeldpK18*mobsacB*-*aroK*Derived from pK18*mobsacB*, carrying *aroK* geneThis studypK18*mobsacB*-*∆aroK*Derived from pK18*mobsacB*-*aroK*, a 573 bp fragment of *aroK* was deletedThis studypUC19-RiboJpUC19 carrying RiboJSangon BiotechpACGFPPlasmid carrying enhanced green fluorescence protein (GFP) geneInvitrogenpXMJ19Shuttle vector (Cam^r^, P*tac*, *lacIq*, pBL1 *oriV* ~*C.glu.*~ pK18 *oriV* ~*E.\ coli.*~)University of BielefeldpXMJ19-RiboJpXMJ19 carrying RiboJ geneThis studypZBDerived from pXMJ19, carrying both RiboJ and GFP genesThis studypZB-*aroG*Derived from pZB, carrying *aroG* ^MU^ gene with various RBSThis studypZB-*aroD*Derived from pZB, carrying *aroD* ^MU^ gene with various RBSThis studypZB-*aroB*Derived from pZB, carrying *aroB* ^MU^ gene with various RBSThis studypZB-*aroE*Derived from pZB, carrying *aroE* ^MU^ gene with various RBSThis studypXMJ19-*aroG* ^MU^pXMJ19 carrying *aroG* of which recognition sites of HindIII and PstI were mutatedThis studypXMJ19-*aroB* ^MU^pXMJ19 carrying *aroB* of which recognition sites of BamHI and SpeI were mutatedThis studypXMJ19-*aroD* ^MU^pXMJ19 carrying *aroD* of which recognition site of PstI were mutatedThis studypXMJ19-*aroE* ^MU^pXMJ19 carrying *aroE* of which the recognition sites of EcoRI and SalI were mutatedThis studypXMJ19-RiboJ-*aroG* ^MU^-HpXMJ19 carrying RiboJ and *aroG* ^MU^ gene with high strength RBSThis studypXMJ19-RiboJ-*aroG* ^MU^-MpXMJ19 carrying RiboJ and *aroG* ^MU^ gene with medium strength RBSThis studypXMJ19-RiboJ-*aroG* ^MU^-LpXMJ19 carrying RiboJ and *aroG* ^MU^ gene with low strength RBSThis studypXMJ19-RiboJ-*aroB* ^MU^-HpXMJ19 carrying RiboJ and *aroB* ^MU^ gene with high strength RBSThis studypXMJ19-RiboJ-*aroB* ^MU^-MpXMJ19 carrying RiboJ and *aroB* ^MU^ gene with medium strength RBSThis studypXMJ19-RiboJ-*aroB* ^MU^-LpXMJ19 carrying RiboJ and *aroB* ^MU^ gene with low strength RBSThis studypXMJ19-RiboJ-*aroD* ^MU^-HpXMJ19 carrying RiboJ and *aroD* ^MU^ gene with high strength RBSThis studypXMJ19-RiboJ-*aroD* ^MU^-MpXMJ19 carrying RiboJ and *aroD* ^MU^ gene with medium strength RBSThis studypXMJ19-RiboJ-*aroD* ^MU^-LpXMJ19 carrying RiboJ and *aroD* ^MU^ gene with low strength RBSThis studypXMJ19-RiboJ-*aroE* ^MU^-HpXMJ19 carrying RiboJ and *aroE* ^MU^ gene with high strength RBSThis studypXMJ19-RiboJ-*aroE* ^MU^-MpXMJ19 carrying RiboJ and *aroE* ^MU^ gene with medium strength RBSThis studypXMJ19-RiboJ-*aroE* ^MU^-LpXMJ19 carrying RiboJ and *aroE* ^MU^ gene with low strength RBSThis studypXMJ19-GHBHPlasmid pXMJ19-RiboJ-aroG^MU^-H derivate, containing *aroB*-H module (Ptac-RiboJ-*aroB*, *aroB* gene with high strength RBS)This studypXMJ19-GHBHDHpXMJ19-GHBH derivate, containing *aroD*-H module (Ptac-RiboJ-*aroD*, *aroD* gene with high strength RBS)This studyplasmid-1pXMJ19-GHBHDH derivate, containing *aroE*-H module (Ptac-RiboJ-*aroE*, *aroE* gene with high strength RBS)This studyplasmid-2Plasmid pXMJ19-RiboJ-*aroG* ^MU^-H derivate, containing *aroB*-M module, *aroD*-M module, *aroE*-M moduleThis studyplasmid-3Plasmid pXMJ19-RiboJ-*aroG* ^MU^-H derivate, containing *aroB*-L module, *aroD*-L module, *aroE*-L moduleThis studyplasmid-4Plasmid pXMJ19-RiboJ-*aro*G^MU^-M derivate, containing *aro*B-H module, *aro*D-M module, *aroE*-L moduleThis studyplasmid-5Plasmid pXMJ19-RiboJ-*aroG* ^MU^-M derivate, containing *aroB*-M module, *aroD*-L module, *aroE*-H moduleThis studyplasmid-6Plasmid pXMJ19-RiboJ-*aroG* ^MU^-M derivate, containing *aroB*-L module, *aroD*-H module, *aroE*-M moduleThis studyplasmid-7Plasmid pXMJ19-RiboJ-*aroG* ^MU^-L derivate, containing *aroB*-H module, *aroD*-L module, *aroE*-M moduleThis studyplasmid-8Plasmid pXMJ19-RiboJ-*aroG* ^MU^-L derivate, containing *aroB*-M module, *aroD*-H module, *aroE*-L moduleThis studyplasmid-9Plasmid pXMJ19-RiboJ-*aroG* ^MU^-L derivate, containing *aroB*-L module, *aroD*-M module, *aroE*-H moduleThis studypXMJ19-GBTDEPlasmid 2 derivate, containing a terminator between *aroB* and *aroD* ModuleThis studypXMJ19-GBTDTEPlasmid pXMJ19-GBTDE derivate, containing a terminator between *aroD* and *aroE* moduleThis studypXMJ19-GTBTDTEPlasmid pXMJ19-GBTDTE derivate, containing a terminator between *aroG* and *aroB* moduleThis studyFig. 5Production of shikimic acid by *C. glutamicum* RES167Δ*aroK* harboring various genetic modules. Three cultivations were conducted in 250-mL flasks and the standard deviations of shikimic acid production are indicated

Insertion of transcriptional terminators into genetic modules further increased SA production with *C. glutamicum* {#Sec6}
------------------------------------------------------------------------------------------------------------------

The genetic module G^H^B^M^D^M^E^M^ was designed that there is a tac promoter for each gene but only one terminator after the last gene (Fig. [4](#Fig4){ref-type="fig"}a). Since terminator regulates also gene transcription and subsequently translation, 3 new SA pathway modules with insertion of terminators were constructed (Fig. [6](#Fig6){ref-type="fig"}a). The SA productions with those new combinations by *C. glutamicum* are shown in Fig. [6](#Fig6){ref-type="fig"}b. It was found that insertion of a terminator between *aroB* and *aroD* (G^H^B^M^TD^M^E^M^) resulted in improvement of SA production by about 56 % (Fig. [6](#Fig6){ref-type="fig"}b).Fig. 6Insertion of transcriptional terminators into genetic modules at various position (**a**) and their effects on shikimic acid production by *C. glutamicum* RES167*ΔaroK* (**b**). In panel B, three cultivations were conducted in 250-mL flasks and the standard deviations of shikimic acid production are indicated

SA production in 250-mL flasks and 5-L fermenters with *C. glutamicum* RES167*ΔaroK*/pXMJ19-GBTDE {#Sec7}
-------------------------------------------------------------------------------------------------

To evaluate SA productivity, *C. glutamicum* RES167*ΔaroK*/pXMJ19-GBTDE was cultivated in 250-mL flasks and 5-L fermenters. Cell growth, SA production, consumption of sucrose and accumulation of 3-dehydroshikimate were monitored (Fig. [7](#Fig7){ref-type="fig"}a, [7](#Fig7){ref-type="fig"}b, [7](#Fig7){ref-type="fig"}c). SA productions were 4.3, 7.4, and 11.3 g/L during 250-mL flask, 5-L batch and fed-batch fermentations, respectively. SA yields from sucrose were 0.22, 0.39, 0.24 mol SA per mole sucrose consumption.Fig. 7The growth (solid squares), sucrose consumption (open squares), productions of shikimic acid (circles) and 3-dehydroshikimic acid (open circles) with recombinant *C. glutamicum* RES167*ΔaroK* harboring pXMJ19-GBTDE, during shake-flask (**a**), batch (**b**), and fed-batch cultivation (**c**). Data are averages of three parallel fermentations

Discussion {#Sec8}
==========

Several methods, such as overexpression of *aro* genes \[[@CR31], [@CR32]\] and the use of enzymes with improved properties \[[@CR33]\], have been reported to enhance the metabolic flux into SA pathway, thus finally increase the production of aromatic amino acids or shikimic acid. This current study revealed a new synthetic biology strategy: Four *aro* genes were organized as continuous genetic modules and their transcriptions were coordinated by the same tac promoter, RiboJ and terminator. The translation levels of *aro* genes in the genetic modules were regulated by their RBS, which were quantatively characterized in this study.

RBS is vital to initiate genetic translation, and are useful synthetic biology parts for construction modules \[[@CR16]\]. In this study, four tailored-made RBS libraries were constructed and the strength of each RBS sequence was determined in the background of *C. glutamicum* cells. Although the RBS libraries were tailored for *aroG*, *aroB*, *aroD* and *aroE*, it is believed that these RBS would be applicable also for other purposes when *C. glutamicum* was used as host. Similarly, the constructed SA pathway modules were tested for SA production in this study, they should be also useful for productions such as aromatic amino acids that are derived from SA pathway.

SA is a highly valued commercial compound. Efforts were made to improve SA production by de-repressing of feedback inhibition of enzymes involved in SA synthesis \[[@CR33]\], increasing glucose availability \[[@CR34]\], and optimizing metabolic fluxes \[[@CR31]\], with *E. coli* or *B. subtilis*. So far as we know, *C. glutamicum* has not been exploited for SA production. By implementing the constructed genetic modules in the shikimate kinase deficient mutant, *C. glutamicum* was successfully engineered to produce SA at 11.3 g/L in 5-L fermenter. So far, this represents the highest titer of SA production with *C. glutamicum*. The SA production with *C. glutamicum* is comparable to the productivity with *B. subtilis* (19.7 g/L) \[[@CR35]\]. Although this SA titer is lower when compared to SA production by *E. coli* (84 g/L) \[[@CR33]\], *C. glutamicum* is still a promising SA producer due to its non-pathogenic nature, and its productivity can be further improved by optimization of fermentation process, or by replacement of the tryptophan- and prephenate-sensitive DAHP synthase \[[@CR36], [@CR37]\].

Conclusion {#Sec9}
==========

Synthetic biology tool boxes for manipulating *C. glutamicum* were expanded by including 4 RBS libraries, in addition to the previous reported promoters \[[@CR38], [@CR39]\] and CoryneBrick \[[@CR40]\]. The RBS libraries represent the first set of RBS libraries that were quantatively characterized in *C. glutamicum*. The selected RBS and *aro* genes could be organized as continuous genetic modules and their transcriptions could be coordinated. Genetic modules were successful constructed for SA pathway, and were demonstrated to be useful for increase of SA synthesis. In fed-batch fermentation, *C. glutamicum* harboring newly constructed SA pathway modules achieved 11.3 g/L SA, which represented the highest SA production with *C. glutamicum.*

Materials and methods {#Sec10}
=====================

Microorganisms, plasmids, medium, and cultivation {#Sec11}
-------------------------------------------------

The bacterial strains and plasmids used in this study are listed in Table [1](#Tab1){ref-type="table"}. *C. glutamicum* was cultivated at 30 °C in Luria Bertani (LB) \[[@CR41]\] broth or Brain Heart Infusion (BHI) medium \[[@CR42]\]. *E. coli* was cultivated at 37 °C in 50 mL of LB broth in 250-ml flasks on a rotary shaker at 200 rpm. When needed, chloramphenicol at a final concentration of 10 or 20 μg/mL in medium was used for cultivation of *C. glutamicum* or *E. coli*. Expression of genes with *C. glutamicum* was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG).

Fermentative production of shikimic acid with *C. glutamicum* was carried out in 250 mL flasks and 5-L fermenter (Bioflo Model 3000 bioreactor, New Brunswick Scientific, N.J., U.S.A.). Seeding cultures were grown with Medium A (g/L): K~2~HPO~4~ · 3H~2~O (0.5); KH~2~PO~4~ (0.5); (NH~4~)~2~SO~4~ (10); glucose (40); MgSO~4~ · 7H~2~O (0.2); phenylalanine (0.15); tyrosine (0.15); tryptophan (0.15); CaCO~3~ (30); FeSO~4~ · 7H~2~O (0.02); MnSO~4~ · 4H~2~O (0.02); biotin (50 μg); thiamine (200 μg), pH 7.4.

Fermentation was conducted with Medium B (g/L): K~2~HPO~4~ · 3H~2~O (0.5); KH~2~PO~4~ (0.5); Urea (3); sucrose (38); MgSO~4~ · 7H~2~O (0.2); Yeast extract (10); peptone (4); FeSO~4~ · 7H~2~O (0.02); MnSO~4~ · 4H~2~O (0.02); biotin (50 μg); thiamine (200 μg), pH 7.4. The fermenter was stirred at 300 rpm, aerated at 3.0 vol/vol per minute, and pH was maintained at 7.0. Cell growth was monitored by measuring optical density at 600 nm (OD~600~) with a spectrophotometer (Biospec-1601 DNA/Protein Enzyme Analyzer, Shimadzu). Cellular dry weights were determined by centrifugation and lyophilization with 3 parallel samples.

*C. glutamicum* was cultivated in mineral salts (MS) medium when RBS strength were tested. The MS medium contained following components (g/L, pH 8.0): Na~2~HPO~4~ · 12H~2~O (2); KH~2~PO~4~ (0.5); MgSO~4~ · 7H~2~O (0.03); NH~4~C1 (0.53); trace element solution 2 mL. Trace element solution (g/L, pH 6.0): EDTA, (0.5); ZnSO~4~ · 7H~2~O, (0.22); CaCl~2~, (0.055); MnCl~2~ · 4H~2~O, (0.051); FeSO~4~ · 7H~2~O, (0.0499); (NH~4~)~6~Mo~7~O~24~ · 4H~2~O, (0.011); CuSO~4~ · 5H~2~O, (0.0157); CoCl~2~ · 6H~2~O, (0.0161); biotin (0.0125); thiamine (0.05).

DNA extraction, amplification, plasmid construction and genetic transformation {#Sec12}
------------------------------------------------------------------------------

Plasmid and chromosomal DNAs were isolated using the OMEGA Plasmid Mini Kit and the OMEGA Bacterial DNA Kit (Omega genetics, Beijing), respectively. DNA fragments from PCR amplification were purified with the OMEGA Cycle-Pure Kit (Omega genetics, Beijing). Restriction enzymes, ligases and other DNA-manipulating enzymes were used according to their manufacturer's instructions. Genetic transformation of *C. glutamicum* and *E. coli* was carried out by electroporation, and recombinant strains were selected according to Tauch *et al.* \[[@CR43]\].

Construction of pXMJ19-*aroG*^MU^, pXMJ19-*aroD*^MU^ pXMJ19-*aroB*^MU^, pXMJ19-*aroE*^MU^ and pZB {#Sec13}
-------------------------------------------------------------------------------------------------

The *aro* genes, *i.e.*, *aroG* (GenBank accession number, NP_601382.1), *aroB* (NP_600835.1), *aroD* (NP_599670.1), and *aroE* (NP_600843.1) were PCR amplified from genomic DNA of *C. glutamicum* RES167 using primers listed in Table [2](#Tab2){ref-type="table"}. Subsequently, these *aro* genes were cloned into pXMJ19, generating pXMJ19-*aroG*, pXMJ19-*aroB*, pXMJ19-*aroD*, and pXMJ19-*aroE*. For subsequent cloning, the following silent mutations were made with primers listed in Table [1](#Tab1){ref-type="table"}: the HindIII and PstI of *aroG*, BamHI and SpeI of *aroB*, PstI of *aroD*, and EcoRI and SalI of *aroE.* The resulting plasmids were named pXMJ19-*aroG*^MU^, pXMJ19-*aroB*^MU^, pXMJ19-*aroD*^MU^, and pXMJ19-*aroE*^MU^.Table 2Oligonucleotides used in this studyPrimersSequencesNotes*aroG*-FCGCGC[GTCGAC]{.ul}ATGAATAGGGGTGTGAGTTGAmplification of *aroG* from genome, SalI and KpnI underlined*aroG*-RCGCGC[GGTACC]{.ul}TTAGTTACGCAGCATTTCTGCAACG*aroB*-FCGCGC[GTCGAC]{.ul}ATGAGCGCAGTGCAGATTTTCAmplification of *aroB* from genome, SalI and KpnI underlined*aroB*-RCGCGC[GGTACC]{.ul}TTAGTGGCTGATTGCCTCATAGCA*aroD*-FCGCGC[GTCGAC]{.ul}ATGCCTGGAA AAATTCTCCTAmplification of *aroD* from genome, SalI and KpnI underlined*aroD*-RCGCGC[GGTACC]{.ul}TTACTTTTTGAGATTTGCCAGGATA*aroE*-FCGCGC[CTGCAT]{.ul}ATGGGTTCTCACATCACTCACAmplification of *aroE* from genome, PstI and KpnI underlined*aroE*-RCGCGC[GGTACC]{.ul}TTAGTGTTCTTCTGAGATGCCTMU-*aroG*-1-FGGCCTTACCGTTGGCAACATCAGC[CAGCTT]{.ul}CTGCTTCAGCTCAAGTACCMutate HindIII in *aroG*MU-*aroG*-1-RCCTGAGGTACTTGAGCTGAAGCAG[AAGCTG]{.ul}GCTGATGTTG CCAACGGTMU-*aroG*-2-FTCGCGCCAACGTAAAGACTCTG[CTCCAG]{.ul}ATGGCAGTTGTTTTGACCTMutate PstI in *aroG*MU-*aroG*-2-RCGTAGGTCAAAACAACTGCCAT[CTGGAG]{.ul}CAGAGTCTTTACGTTGGCGCMU-*aroG*-3-FGTGTCCGATGAGTCCCTGCGTG[CTGCCG]{.ul}ATATCTACTGCTCCCACGAGGMutate PstI in *aroG*MU-*aroG*-3-RAGCCTCGTGGGAGCAGTAGATAT[CGGCAG]{.ul}CACGCAGGGACTCATCGGACMU-*aroB*-1-FGCCTGACGCGGAAATCATCGCG[GGTTCC]{.ul}GCCGAAATCATCAAAACTGGMutate BamHI in *aroB*MU-*aroB*-1-RAACCAGTTTTGATGATTTCGGC[GGAACC]{.ul}CGCGATGATTTCCGCGTCAGGMU-*aroB*-2-FCATCCGAGTTGGATGCAGC[ACTGGT]{.ul}CGCTGCTGGTTTGAAGGTCCTGCMutate SpeI in *aroB*MU-*aroB*-2-RTGCAGGACCTTCAAACCAGCAGCG[ACCAGT]{.ul}GCTGCATCCAACTCGGATGMU-*aroD*-FTTAGCTCACCTTCGTGATTGCT[CTGGAG]{.ul}CGCCTCAACCTCAAGGCCGTGMutate PstI in *aroD*MU-*aroD*-RGCACGGCCTTGAGGTTGAGGCG[CTCCAG]{.ul}AGCAATCACGAAGGTGAGCTMU-*aroE*-2-FCATGCCGTCTAAATTCGCAGCTCTT[GAATTT]{.ul}GCCGACGAAGTAACCGAACGCGCCTGCMutate EcoRI in *aroE*MU-*aroE*-2-RGCAGGCGCGTTCGGTTACTTCGTCGGC[AAATTC]{.ul}AAGAGCTGCGAATTTAGACGGCATGMU-*aroE*-2-FATGGCGCGCCGACAACACCGAC[GTTGAC]{.ul}GGCATCAGGGGAGCTCTCGGMutate SalI in aroEMU-*aroE*-2-RCACCGAGAGCTCCCCTGATGCC[GTCAAC]{.ul}GTCGGTGTTGTCGGCGCGCCRiboJ-FCGCG[AAGCTT]{.ul}AGCTGTCACCGGATGTGCTTTCCGGTCTGATGAGTCAmplification of RiboJ from pUC19, HindIII and PstI underlinedRiboJ-RCGCG[CTGCAG]{.ul}TTAAACAAAATTATTTGTAGAGGCTGTTTCGEGFP-FCGCG[GGTACC]{.ul}GTGAGCAAGGGCGCCGAGCAmplification of *egfp* from pACGFP, KpnI and EcoRI underlinedEGFP-RCGCG[GAATTC]{.ul}TCACTTGTACAGCTCATCCATGCCGTGGGTMU-RBSAG-FCGCGC[GTCGAC]{.ul}AAAGGNNNNNNNNATGAATAGGGGTGTGAGTTGAmplification of aroG with mutated RBS, SalI and KpnI underlinedMU-RBSAG-RCGCGC[GGTACC]{.ul}GTTACGCAGCATTTCTGCAACGMU-RBSAB-FCGCGC[GTCGAC]{.ul}AAAGGNNNNNNNNATGAGCGCAGTGCAGATTTTCAmplification of aroB with mutated RBS, SalI and KpnI underlinedMU-RBSAB-RCGCGC[GGTACC]{.ul}GTGGCTGATTGCCTCATAAGCAMU-RBSAD-FCGCGC[GTCGAC]{.ul}AAAGGNNNNNNNNATGCCTGGAAAAATTCTCCTAmplification of aroD with mutated RBS, SalI and KpnI underlinedMU-RBSAD-RCGCGC[GGTACC]{.ul}CTTTTTGAGATTTGCCAGGATAMU-RBSAE-FCGCGC[GTCGAC]{.ul}AAAGGNNNNNNNNATGGGTTCTCACATCACTCACAmplification of aroE with mutated RBS, SalI and KpnI underlinedMU-RBSAE-RCGCGC[GGTACC]{.ul}GTGTTCTTCTGAGATGCCT*aroG*-H-FCGCGC[GTCGAC]{.ul}AAAGGGTGAATCTATGAATAGGGGTGTGAGTTGaroG with high strength RBS, SalI and BamHI underlined*aroG*-H-RCGCGC[GGATCC]{.ul}TTAGTTACGCAGCATTTCTGCAACG*aroG*-M-FCGCGC[GTCGAC]{.ul}AAAGGTTCTAAAGATGAATAGGGGTGTGAGTTGaroG with medium strength RBS, SalI and BamHI underlined*aroG*-M-RCGCGC[GGATCC]{.ul}TTAGTTACGCAGCATTTCTGCAACG*aroG-*L-FCGCGC[GTCGAC]{.ul}AAAGGGCCGAATTATGAATAGGGGTGTGAGTTGaroG with lows trength RBS, SalI and BamHI underlined*aroG*-L-RCGCGC[GGATCC]{.ul}TTAGTTACGCAGCATTTCTGCAACG*aroB*-H-FCGCGC[GTCGAC]{.ul}AAAGGGGAGAGCCATGAGCGCAGTGCAGATTTTCaroB with high strength RBS, SalI and BamHI underlined*aroB*-H-RCGCGC[GGATCC]{.ul}TTAGTGGCTGATTGCCTCATAAGCA*aroB*-M-FCGCGC[GTCGAC]{.ul}AAAGGCATGTTCTATGAGCGCAGTGCAGATTTTCaroB with medium strength RBS, SalI and BamHI underlined*aroB*-M-RCGCGC[GGATCC]{.ul}TTAGTGGCTGATTGCCTCATAAGCA*aroB*-L-FCGCGC[GTCGAC]{.ul}AAAGGAACGACTAATGAGCGCAGTGCAGATTTTCaroB with low strength RBS, SalI and BamHIunderlined*aroB-*L-RCGCGC[GGATCC]{.ul}TTAGTGGCTGATTGCCTCATAAGCA*aroD*-H-FCGCGC[GTCGAC]{.ul}AAAGGAGGTTGTCATGCCTGGAAAAATTCTCCTaroD with high strength RBS, SalI and BamHI underlined*aroD*-H-RCGCGC[GGATCC]{.ul}TTACTTTTTGAGATTTGCCAGGATA*aroD*-M-FCGCGC[GTCGAC]{.ul}AAAGGCATGGCCGATGCCTGGAAAAATTCTCCTaroD with medium strength RBS, SalI and BamHI underlined*aroD*-M-RCGCGC[GGATCC]{.ul}TTACTTTTTGAGATTTGCCAGGATA*aroD*-L-FCGCGC[GTCGAC]{.ul}AAAGGTGGTTCATATGCCTGGAAAAATTCTCCTaroD with low strength RBS, SalI and BamHI underlined*aroD*-L-RCGCGC[GGATCC]{.ul}TTACTTTTTGAGATTTGCCAGGATA*aroE*-H-FCGCGC[GTCGAC]{.ul}AAAGGAGGATTAGATGGGTTCTCACATCACTCACaroE with high strength RBS, SalI and BamHI underlined*aroE*-H-RCGCGC[GGATCC]{.ul}TTAGTGTTCTTCTGAGATGCCT*aroE*-M-FCGCGC[GTCGAC]{.ul}AAAGGAGAACGTGATGGGTTCTCACATCACTCACaroE with medium strength RBS, SalI and BamHI underlined*aroE*-M-RCGCGC[GGATCC]{.ul}TTAGTGTTCTTCTGAGATGCCT*aroE*-L-FCGCGC[GTCGAC]{.ul}AAAGGGTTCATAGATGGGTTCTCACATCACTCACaroE with low strength RBS, SalI and BamHI underlined*aroE*-L-RCGCGC[GGATCC]{.ul}TTAGTGTTCTTCTGAGATGCCTPB-FCGCG[GGATCC]{.ul}TTGCGCCGACATCATAACGGTTBamHI and XmaI underlinedPB-RCGCG[CCCGGG]{.ul}TTAGTGGCTGATTGCCTCATAAGCAPD-FCGCG[CCCGGG]{.ul}TTGCGCCGACATCATAACGGTTXmaI and KpnI underlinedPD-RCGCG[GGTACC]{.ul}TTACTTTTTGAGATTTGCCAGGATAPE-FCGCG[GGTACC]{.ul}TTGCGCCGACATCATAACGGTTKpnI and EcoRI underlinedPE-RCGCG[GAATTC]{.ul}TTAGTGTTCTTCTGAGATGCCTTerminator 1-FCGCG[CCCGGG]{.ul}GGCTGTTTTGGCGGATGAGAGAAGATTTTCXmaI underlinedTerminator 1-RCGCG[CCCGGG]{.ul}AGAGTTTGTAGAAACGCAAAAAGGCCTerminator 2-FCGCG[GGTACC]{.ul}GGCTGTTTTGGCGGATGAGAGAAGATTTTCKpnI underlinedTerminator 2-RCGCG[GGTACC]{.ul}AGAGTTTGTAGAAACGCAAAAAGGCCTerminator 3-FCGCG[GGATCC]{.ul}GGCTGTTTTGGCGGATGAGAGAAGATTTTCBamHI underlinedTerminator 3-RCGCG[GGATCC]{.ul}AGAGTTTGTAGAAACGCAAAAAGGCC*aroK*-FCGCG[GAATTC]{.ul}TGGCTGATTGCCTCATAAGCACTCTEcoRI and HindIII underlined*aroK*-RCGCG[AAGCTT]{.ul}TTCGATGGACTACAGCAGGTGAATCKT*aroK*-FCGCG[CCCGGG]{.ul}CCTCTAAACCTTCGAATTTCATTCGTTCCTCXmaI underlinedKT*aroK*-RCGCG[CCCGGG]{.ul}CGATTAATTAAACCGGGCACCTGATTAACV-KT*aroK*-FTCCATGCTGGGCTGGTGCAAAATCGCTACCPrimer used to verify Δ*aroK*V-KT*aroK*-RAACCATTGATATGGAAAACGGCAAGGCAGC

pZB was derived from pXMJ19. Chemically synthesized gene of RiboJ (27) was cloned into pXMJ19 at HindIII and PstI sites, resulting in pXMJ19-RiboJ. This pXMJ19-RiboJ was digested with EcoRI and KpnI, and a genetic fragment encoding the enhanced green fluorescence protein was cloned at the KpnI and EcoRI sites. The resulting plasmid was named pZB, and was used for later construction of RBS libraries.

Design and construction of RBS libraries tailored for *aroG*, *aroB*, *aroD* and *aroE*, and evaluation of RBS strength according to fluorescence intensity {#Sec14}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

Based on the currently known RBS sequences from *C. glutamicum*, we designed a seeding sequence of AAAGG(N)~6--9~, where "N" represents any nucleotide of A, T, G, or C. From this seeding sequence, oligonucleotides tagged as MU-RBSAG-F, MU-RBSAB-F, MU-RBSAD-F, and MU-RBSAE-F, were chemically synthesized. These oligonucleotides and their partner primers (Table [2](#Tab2){ref-type="table"}) were used to amplify the *aro* genes from plasmid pXMJ19-*aroG*^MU^, pXMJ19-*aroB*^MU^, pXMJ19-*aroD*^MU^, pXMJ19-*aroE*^MU^. The amplified *aro* genes, each had a specific RBS sequence at its 5'-end, were digested with restriction endonuclease and were cloned into the samely digested pZB. Thus, four RBS libraries were constructed and were named as pZB-*aroG*, pZB-*aroB*, pZB-*aroD*, and pZB-*aroE* (Fig. [2](#Fig2){ref-type="fig"}).

The strength of each RBS for genetic translation was determined according to its fluorescence intensity. *C. glutamicum* cells harboring single plasmid (thus a single RBS) of libraries of pZB-*aroG*, pZB-*aroB*, pZB-*aroD*, and pZB-*aroE* were cultivated in the presence of 0.5 mM IPTG at 30 °C in MS medium. After incubation for 48 h at 30 °C and 200 rpm, 200 μl of cell suspension was transferred into a 96-well plate. The fluorescence from the eGFP in *C. glutamicum* cells and optical density were measured using a BioTek® synergy H4 Hybrid Reader (Keruiente, Beijing, China).

Construction of genetic modules for SA pathway {#Sec15}
----------------------------------------------

To construct the nine plasmids with the combination of different strength RBS, *aroG* gene with high, middle and low strength RBS were amplified from pXMJ19-*aroG*^MU^ and cloned between SalI and BamHI cloning sites of plasmid pXMJ19-RiboJ. These three plasmids were named as pXMJ19-RiboJ-*aroG*^MU^-H, pXMJ19-RiboJ-*aroG*^MU^-M and pXMJ19-RiboJ-*aroG*^MU^-L, respectively. Taking the same way, we got plasmids pXMJ19-RiboJ-*aroB*^MU^-H, pXMJ19-RiboJ-*aroB*^MU^-M, pXMJ19-RiboJ-*aroB*^MU^-L, pXMJ19-RiboJ-*aroD*^MU^-H, pXMJ19-RiboJ-*aroD*^MU^-M, pXMJ19-RiboJ-*aroD*^MU^-L, pXMJ19-RiboJ-*aroE*^MU^-H, pXMJ19-RiboJ-*aroE*^MU^-M and pXMJ19-RiboJ-*aroE*^MU^-L, which also have the high, middle and low strength RBS, accordingly. Then, Ptac-RiboJ-*aroB*^MU^-H fragments with BamHI and XmaI sites were amplified from plasmid pXMJ19-RiboJ-*aroB*^MU^-H and cloned into plasmid pXMJ19-RiboJ-*aroG*^MU^-H, resulting plasmid named pXMJ19-GHBH. Then fragments Ptac-RiboJ-*aroD*^MU^-H with XmaI and KpnI sites were cloned into plasmid pXMJ19-GHBH, resulting plasmid named pXMJ19-GHBHDH. From plasmid pXMJ19-RiboJ-*aroE*^MU^-H we got fragments Ptac-RiboJ-*aroE*^MU^-H with KpnI and EcoRI sites and cloned the fragments into plasmid pXMJ19-GHBHDH, resulting plasmid named plasmid-1. Plasmid-2 to plasmid-9 and derivate plasmids were also got by the way describe above. Three terminator fragments with XmaI, BamHI and KpnI cloning sites were amplified from plasmid pXMJ19, respectively. After terminator with XmaI site was cloned in plasmid-2, we got plasmid pXMJ19-GBTDE. Then terminator with BamHI site was cloned in plasmid pXMJ19-GBTDE to get plasmid pXMJ19-GBTDTE. Plasmid pXMJ19-GTBTDTE was constructed by cloning terminator with KpnI site.

Measurement of SA dehydrogenase activity {#Sec16}
----------------------------------------

The enzyme activities of the shikimate dehydrogenases were assayed by monitoring the absorbance of NADPH at 340 nm (ε = 6230 M^−1^ cm^−1^) using a spectrophotometer (Specord 205 Analytik, Jena, Germany). The assays were conducted at 25 °C in a volume of 1 mL solution, containing 100 mM Tris--HCl buffer at pH 8.0, 1 mM SA, and 2 mM NADP^+^. Cellular lysates from *C. glutamicum* were added finally to trigger the reaction. One unit of enzyme activity was defined as the amount of enzyme catalyzing the conversion of 1 μmol of NADP^+^ per minute at 25 °C.

For preparation of cellular lysates of *C. glutamicum*, cells were harvested by centrifugation (6000 *g*, 4 °C, 5 min) of culture samples. Supernatants were removed, the cell pellets were washed and re-suspended in 50 mM pH 8.0 Tris--HCl buffer. This cell suspension was subjected to sonication (Ningbo Scientz Biotechnology Co., LTD, China) and centrifugation (12,000 *g*, 4 °C, 10 min). The supernatants were collected and used for enzyme assays. Protein concentrations were determined using Bradford method \[[@CR44]\].

Construction of *C. glutamicum* RES167*∆aroK* {#Sec17}
---------------------------------------------

Disruption of the shikimate kinase gene, *aroK*, in *C. glutamicum* was performed using the suicide vector pK18*mobsacB*. The intact DNA fragment (2946 bp) of *aroK* was amplified from chromosomal DNA of *C. glutamicum*, using the primers *aroK*-F and *aroK*-R (Table [1](#Tab1){ref-type="table"}). This intact aroK fragment was cloned into pK18*mobsacB* EcoRI/HindIII sites. The resulting plasmid was named pK18*mobsacB-aroK*, and was amplified with primers KT*aroK*-F and KT*aroK*-R, thus resulting DNA fragments with disrupted *aroK* gene. After digested with XmaI restriction endonuclease, DNA fragments were ligated and transformed into *E. coli*. The recombinant plasmid was named pK18*mobsacB-∆aroK* and was electroporated into *C. glutamicum* RES167. Using the method described by Schäfer *et al.* \[[@CR45]\], the *aroK* mutant RES167*∆aroK* was screened out on BHI agar plates. The Disruption of *aroK* was verified by PCR amplification and sequence of the disrupted *aroK* gene from RES167*∆aroK*.

Determination of SA and 3-dehydroshikimic acid concentrations {#Sec18}
-------------------------------------------------------------

The concentrations of SA and 3-dehydroskimic acid were determined with an HPLC system (Agilent 1200 series, Agilent Technologies, Inc., USA) equipped with a ZORBAX SB C18 column (4.6 mm x 250 mm x 5 μm) and detected at 215 nm wavelength. The HPLC was run with a mixture of solution A (phosphoric acid in water, pH 2.5) and solution B (methanol) as eluant and was operated at a flow rate of 0.35 mL/min. The following gradient was used: at 0--7.5 min, 95 % of solution A and 5 % of solution B; at 7.5-15 min, 100 % of solution B; 15.0-22.5 min, 95 % of solution A and 5 % of solution B. Standard shikimic acid (Cat. No. S5375, Sigma-Aldrich, USA) and 3-dehydroshikimic acid (Cat. No. 05616, Sigma-Aldrich, USA) were eluted at 5.411 and 6.241 min, respectively, under these conditions.

Determination of sucrose concentrations {#Sec19}
---------------------------------------

The sucrose concentrations in fermentation broth were determined with spectrometric method, as previously described \[[@CR46]\].
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